Melief CJ - Search Results

1

Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escape.

Toes RE, Feltkamp MC, Ressing ME, Vierboom MP, Blom RJ, Brandt RM, Hartman M, Offringa R, Melief CJ, Kast WM. Toes RE, et al. Among authors: melief cj. Biochem Soc Trans. 1995 Aug;23(3):692-6. doi: 10.1042/bst0230692. Biochem Soc Trans. 1995. PMID: 8566445 Review. No abstract available.

2

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM. Ressing ME, et al. Among authors: melief cj. J Immunol. 1995 Jun 1;154(11):5934-43. J Immunol. 1995. PMID: 7538538

3

Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor.

Ossevoort MA, Feltkamp MC, van Veen KJ, Melief CJ, Kast WM. Ossevoort MA, et al. Among authors: melief cj. J Immunother Emphasis Tumor Immunol. 1995 Aug;18(2):86-94. doi: 10.1097/00002371-199508000-00002. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8574470

4

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

Toes RE, Offringa R, Blom RJ, Melief CJ, Kast WM. Toes RE, et al. Among authors: melief cj. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7855-60. doi: 10.1073/pnas.93.15.7855. Proc Natl Acad Sci U S A. 1996. PMID: 8755566 Free PMC article.

5

Peptide-based cancer vaccines.

Melief CJ, Offringa R, Toes RE, Kast WM. Melief CJ, et al. Curr Opin Immunol. 1996 Oct;8(5):651-7. doi: 10.1016/s0952-7915(96)80081-1. Curr Opin Immunol. 1996. PMID: 8902390 Review.

6

Activation or frustration of anti-tumor responses by T-cell-based immune modulation.

Toes RE, Schoenberger SP, van der Voort EI, Kast WM, Hoeben RC, Melief CJ, Offringa R. Toes RE, et al. Among authors: melief cj. Semin Immunol. 1997 Oct;9(5):323-7. doi: 10.1006/smim.1997.0088. Semin Immunol. 1997. PMID: 9327527 Review.

7

Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity.

Ressing ME, Offringa R, Toes RE, Ossendorp F, de Jong JH, Brandt RM, Kast WM, Melief CJ. Ressing ME, et al. Among authors: melief cj. Immunotechnology. 1996 Nov;2(4):241-51. doi: 10.1016/s1380-2933(96)00057-7. Immunotechnology. 1996. PMID: 9373306 Review.

8

Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma.

Ressing ME, de Jong JH, Brandt RM, Drijfhout JW, Benckhuijsen WE, Schreuder GM, Offringa R, Kast WM, Melief CJ. Ressing ME, et al. Among authors: melief cj. Eur J Immunol. 1999 Apr;29(4):1292-303. doi: 10.1002/(SICI)1521-4141(199904)29:04<1292::AID-IMMU1292>3.0.CO;2-6. Eur J Immunol. 1999. PMID: 10229097 Free article.

9

Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilization.

Feltkamp MC, Vierboom MP, Toes RE, Ossendorp F, ter Schegget J, Melief CJ, Kast WM. Feltkamp MC, et al. Among authors: melief cj. Immunol Lett. 1995 Jul-Aug;47(1-2):1-8. doi: 10.1016/0165-2478(95)00052-7. Immunol Lett. 1995. PMID: 8537084

10

Design and development of synthetic peptide vaccines: past, present and future.

Bijker MS, Melief CJ, Offringa R, van der Burg SH. Bijker MS, et al. Among authors: melief cj. Expert Rev Vaccines. 2007 Aug;6(4):591-603. doi: 10.1586/14760584.6.4.591. Expert Rev Vaccines. 2007. PMID: 17669012 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters